Scientists have discovered that losing a key protein in small cell lung cancer triggers inflammation that actually helps ...
Everyday Health on MSN
6 tips to conserve energy and combat fatigue when you have non-small cell lung cancer
Use these six lifestyle habits to conserve energy and fight fatiue during the day.
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
MedPage Today on MSN
First-in-Class KRAS-Degrader Promising in Pancreatic, Lung Cancers
"There is a clear unmet need for therapies," researcher says ...
New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint ...
Is Zepzelca Right for Me? To help choose the right treatment for you, your health care provider will consider what type of lung cancer you have, the treatments you have received, and whether the ...
In this video, Lukas Delasos, DO, discusses the accelerated approval of zongertinib as an initial treatment option for adults ...
The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results